Oculis to Present at Upcoming February Investor Conferences
ZUG, Switzerland and BOSTON, Jan. 29, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq:OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ management will be attending and presenting at the following upcoming investor conferences:
Related news for (OCS)
- Oaktree Specialty Lending Corporation Announces Second Fiscal Quarter 2025 Financial Results
- Oaktree Specialty Lending Corporation Prices Public Offering of $300,000,000 6.340% Notes due 2030
- Doximity Announces Fiscal 2025 Third Quarter Financial Results
- Oaktree Specialty Lending Corporation Announces First Fiscal Quarter 2025 Financial Results
- Oaktree Specialty Lending Corporation Announces Fourth Fiscal Quarter and Full Year 2024 Financial Results and Declares Quarterly Distribution of $0.55 Per Share